¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"paraplacental chorionic defect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • afferent pupillary defect
    µé½Å°æµ¿°ø°á¼Õ, ±¸½É½Å°æµ¿°ø°á¼Õ
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • color vision defect
    »ö°¢°áÇÔ
  • composition defect
    ±¸¼º°áÇÔ
  • conduction defect
    ÀüµµÀå¾Ö
  • congenital defect
    ¼±Ãµ°áÇÔ, ¼±Ãµ°á¼Õ(Áõ)
  • congruous field defect
    ÀÏÄ¡½Ã¾ß°á¼Õ
  • conjunction defect
    °áÇÕ°áÇÔ
  • cortical sensory defect
    °ÑÁú°¨°¢°á¼Õ, ÇÇÁú°¨°¢°á¼Õ
  • canalization defect
    °üÇü¼º°áÇÔ
  • defect
    1. °áÇÔ, °á¼Õ(Áõ) 2. Àå¾Ö
  • defect rate
    °áÇÔ·ü
  • differentiation defect
    ºÐÈ­°áÇÔ
  • endocardial cushion defect
    ½É(Àå)³»¸·À¶±â°á¼Õ
  • field defect
    ½Ã¾ß°á¼Õ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • color vision defect
    »ö°¢°áÇÔ
  • composition defect
    ±¸¼º°áÇÔ
  • conduction defect
    ÀüµµÀå¾Ö
  • congenital defect
    ¼±Ãµ°áÇÔ, ¼±Ãµ°á¼Õ(Áõ)
  • congruous field defect
    ÀÏÄ¡½Ã¾ß°áÇÔ
  • conjunction defect
    °áÇÕ°áÇÔ
  • cortical sensory defect
    °ÑÁú°¨°¢°á¼Õ
  • defect
    °áÇÔ, °á¼Õ(Áõ)
  • defect rate
    °áÇÔ·ü
  • differentiation defect
    ºÐÈ­°áÇÔ
  • endocardial cushion defect
    ½ÉÀå³»¸·À¶±â°á¼Õ
  • field defect
    ½Ã¾ß°á¼Õ
  • fusion defect
    À¶ÇÕ°áÇÔ
  • gene defect
    À¯ÀüÀÚ°á¼Õ
  • genetic defect
    À¯Àü°áÇÔ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • aortic septal defect
    ´ëµ¿¸ÆÁ߰ݰá¼Õ(ÓÞÔÑØæñḛ́ÌÀáß).
  • aortic septal defect
    ´ëµ¿¸ÆÁ߰ݰá¼Õ(ÓÞÔÑØæñḛ́ÌÀáß).
  • aorticopulmonary septal defect
    ´ëµ¿¸ÆÆóµ¿¸ÆÁ߰ݰá¼Õ(¡­ñḛ́ÌÀáß).
  • aorticopulmonary septal defect
    ´ëµ¿¸ÆÆóµ¿¸ÆÁ߰ݰá¼Õ(¡­ñḛ́ÌÀáß).
  • aortopulmonary septal defect
    ´ëµ¿¸ÆÆóµ¿¸ÆÁ߰ݰá¼Õ.
  • aortopulmonary septal defect
    ´ëµ¿¸ÆÆóµ¿¸ÆÁ߰ݰá¼Õ.
  • functional morphologic defect
    ±â´ÉÇüŰáÇÔ
  • fusion defect
    À¶ÇÕ°áÇÔ
  • fusion defect (cleft palate)
    À¶ÇÕ°áÇÔ (ÀÔõÀå°¥¸²Áõ)
  • gametic defect
    »ý½ÄÀÚ°áÇÔ
  • gene defect
    À¯ÀüÀÚ°á¼Õ<--°á¿©>
  • genetic defect
    À¯ÀüÀû °áÇÔ(¡­ÌÀùè).
  • genetic defect
    À¯ÀüÀÚ°áÇÔ
  • genetic defect
    À¯ÀüÀû °áÇÔ.
  • growth defect
    ¼ºÀå°áÇÔ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • chorionic villi
    À¶¸ð¸· À¶¸ð(ØæÕ©Ø¯ëÖÙ¾)
  • chorionic villi
    À¶¸ð¸·À¶¸ð(¡­Ø¯ëÖÙ¾).
  • chorionic villous biopsy
    À¶¸ð¸·À¶¸ð»ý°Ë
  • chorionic villus biopsy
    À¶¸ð¸·À¶¸ð»ý°Ë
  • epithelium of chorionic villi
    À¶¸ð¸·À¶¸ð»ó ÀÇ, À¶¸ð¸·(ëÖپد)»óÇÇ.
  • hCG (Human chorionic gonadotropin)
    ÀÎÀ¶¸ð¸·¼º°í³ªµµÆ®·ÎÇÉ
  • human chorionic gonadotropin =HCG
    »ç¶÷ À¶¸ð¼º(ëÖÙ¾àõ) ¼º¼±ÀÚ±ØÈ£¸£¸ó.
  • human chorionic gonadotropin =HCG
    »ç¶÷À¶¸ð¼º ¼º¼±ÀÚ±ØÈ£¸£¸ó.
  • human chorionic gonadotropin =hCG
    (»ç¶÷)À¶¸ð¼º ¼º¼±ÀÚ±ØÈ£¸£¸ó.
  • human chorionic gonadotropin, HCG
    ÀÎü À¶¸ð¼º ¼º¼±ÀÚ±Ø È£¸£¸ó
  • human chorionic somatotropin
  • villus chorionic
    À¶¸ð¸·(ëÖپد).
  • acquired color vision defect
    ÈÄõ»ö°¢ÀÌ»ó
  • afferent pupillary defect
    ±¸½É¼ºµ¿°ø¿îµ¿Àå¾Ö
  • aggregation defect
    ÀÀÁý°áÇÔ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Functional morphologic defect
    ±â´ÉÇüŰáÇÔ
    [¿¾ ¿ë¾î] ±â´ÉÀûÇüÅÂÇÐÀû°áÇÔ
  • Defect of male urethra
    ³²¼º¿äµµ°áÇÔ
    [¿¾ ¿ë¾î] ³²¼º¿äµµ°áÇÔ
  • Defect of brain
    ³ú°áÇÔ
    [¿¾ ¿ë¾î] ³ú°áÇÔ
  • Perforation defect
    ¶Õ¸²°áÇÔ
    [¿¾ ¿ë¾î] õ°ø°áÇÔ
  • Defect of membranous part
    ¸·ºÎºÐ°áÇÔ
    [¿¾ ¿ë¾î] ¸·¼ººÎ°áÇÔ
  • Defect of Head
    ¸Ó¸®°áÇÔ
    [¿¾ ¿ë¾î] µÎºÎ°áÇÔ
  • Cranial defect
    ¸Ó¸®»À°áÇÔ
    [¿¾ ¿ë¾î] µÎ°³°ñ°áÇÔ
  • Metabolic defect of minerals (Asiderosis)
    ¹«±âÁú´ë»ç°áÇÔ(ö°¨¼ÒÁõ)
    [¿¾ ¿ë¾î] ¹«±âÁú´ë»ç°áÇÔ(ö°¨¼ÒÁõ)
  • Defect of Abdomen
    ¹è°áÇÔ
    [¿¾ ¿ë¾î] º¹ºÎ°áÇÔ
  • Subtotal heart defect
    ºÎºÐ½ÉÀå°áÇÔ
    [¿¾ ¿ë¾î] ½ÉÀåºÎºÐ°áÇÔ
  • Separation defect
    ºÐ¸®°áÇÔ
    [¿¾ ¿ë¾î] ºÐ¸®°áÇÔ
  • Separation defect (Syndactylia)
    ºÐ¸®°áÇÔ (¼Õ°¡¶ôÀ¶ÇÕÁõ)
    [¿¾ ¿ë¾î] ºÐ¸®°áÇÔ (¼Õ°¡¶ôÀ¶ÇÕÁõ)
  • Cleavage defect
    ºÐÇÒ°áÇÔ
    [¿¾ ¿ë¾î] ³­ÇÒ°áÇÔ
  • Differentiation defect
    ºÐÈ­°áÇÔ
    [¿¾ ¿ë¾î] ºÐÈ­°áÇÔ
  • Defect of urogenital organ
    ºñ´¢»ý½Ä±â°ü°áÇÔ
    [¿¾ ¿ë¾î] ºñ´¢»ý½Ä±â°ü°áÇÔ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
hPL human Placental Lactogen
  = Chorionic Somatomammotropin
bHCG beta human chorionic gonadotropin
CG cardiography; cardiogreen; choking gas; choriogenic gynecomastia; chorionic gonadotropin; chromogran...
CGH chorionic gonadotropic hormone
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PD Perfusion defect
RAPD Relative afferent pupillary defect
TDS Total defect score
VSD Ventricular Septal Defect
ECD endocardial cushion defect
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • catalase defect
    īŻ¶óÁ¦ °á¼Õ
  • congenital defect
    ¼±Ãµ¼º °á¼Õ, ¼±Ãµ¼º °á¼ÕÁõ, ¼±ÃµÀû °á¼Õ
  • congenital heart defect
    ¼±Ãµ¼º ½É³» °á¼ÕÁõ
  • defect
    °á¼Õ, °á¿©, ±âÇü, °áÇÔ, ºÎÀü, ºÎÀç, ¼Õ»ó
  • ectodermal defect
    ¿Ü¹è¿± °á¼Õ, ¿Ü¹è¿± °á¼ÕÁõ
  • enzymatic defect
    È¿¼Ò °á¼ÕÁõ, È¿¼Ò °á¼Õ
  • filling defect
    Ãæ¸¸ °á¼Õ
  • hearing defect
    û·Â Àå¾Ö
    ºÎºÐÀûÀ¸·Î ȤÀº ¿ÏÀüÈ÷ µé¸®Áö ¾Ê´Â °Í.
  • heart septal defect
    ½É Áß°Ý °á¼Õ, ½É Áß°Ý °á¼ÕÁõ
  • interventricular septal defect
    ½É½Ç Áß°Ý °á¼ÕÁõ
  • metabolic defect of amino acid
    ¾Æ¹Ì³ë»ê ´ë»ç °áÇÔ
    ¾Ëİſ ´¢Áõ.
  • metabolic defect of pigment
    »ö¼Ò ´ë»ç °áÇÔ
  • morphologic defect
    ÇüÅ °áÇÔ
  • ostium primum atrial septal defect
    ÀÏÂ÷ °øÇü ½É¹æ Áß°Ý °á¼Õ
  • perceptual defect
    Áö°¢ °á¼Õ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
chorionic villus biopsy Transcervical or transabdominal sampling of the chorionic villi for genetic analysis.
(05 Mar 2000)
chorionic villus sampling <procedure> A procedure for obtaining a sample of chorionic villi for the purpose of genetic testing, usually performed between 9 and 12th weeks of pregnancy.
Amniocentesis testing has greatly supplanted the use of this form of genetic testing.
(27 Sep 1997)
hormone, human chorionic gonadotropin A human hormone made by chorionic cells (in the foetal part of the placenta), hcg is directed at the gonads and stimulates them. Hcg becomes detectable (by immunologic means) within days of the time of fertilization. It therefore forms the foundation of most common pregnancy tests. The level of hcg in maternal serum enters as one component in the double and the triple screens used during pregnancy to assign risks of down syndrome and other foetal disorders.
(12 Dec 1998)
human chorionic gonadotrophin <hormone, tumour marker> A hormone that is produced by the developing placenta and by the fertilized egg after implantation in the uterine wall.
This hormone is measured in the blood to determine pregnancy. Human chorionic gonadotrophin increases in quantity through the first trimester of pregnancy and begin to taper off after 85 days.
Serum human chorionic gonadotrophin testing is accurate 48 hour post conception. Urine human chorionic gonadotrophin testing is a popular method of home pregnancy determination as human chorionic gonadotrophin can be detected in urine.
Acronym: HCG
(18 Nov 1997)
human chorionic gonadotropin A human hormone made by chorionic cells (in the foetal part of the placenta), hcg is directed at the gonads and stimulates them. Hcg becomes detectable (by immunologic means) within days of fertilization and forms the foundation of the common pregnancy tests. The level of hcg in maternal serum also enters as one component in the double and the triple screens used during pregnancy to assign risks of down syndrome and other foetal disorders.
(12 Dec 1998)
human chorionic somatomammotropic hormone human placental lactogen
human chorionic somatomammotropin human placental lactogen
acquired platelet function defect <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines).
Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation.
(29 Dec 1997)
aortic septal defect A small congenital opening between the aorta and pulmonary artery about 1 cm above the semilunar valves, e.g., aorticopulmonary window.
Synonym: aorticopulmonary window.
(05 Mar 2000)
aortopulmonary septal defect A congenital anomaly in which there is abnormal communication between the ascending aorta and pulmonary artery just above the semilunar valves.
(12 Dec 1998)
atrial septal defect <cardiology> An inherited condition where there is nonclosure of the foramen ovale at birth, resulting in congenital heart disease. Usually asymptomatic until the third or fourth decades of life.
Symptoms include exertional shortness of breath, fatigue and palpitations.
Acronym: ASD
(12 Jan 1998)
atrial ventricular canal defect A defect caused by deficient or absent septal tissue immediately above and below the normal level of the atrioventricular valves, including the region normally occupied by the A-V septum in hearts with two ventricles. The A-V valves are abnormal to a varying degree.
(05 Mar 2000)
birth defect Defect present at birth; sometimes referred to as congenital defect.
(05 Mar 2000)
ventricular septal defect <cardiology, embryology> A congenital heart defect where an abnormal opening exists in the ventricular septum. Blood flows from the higher pressure left ventricle (through the defect) into the right ventricle.
(12 Jan 1998)
Gerbode defect <cardiology, embryology> A defect in the interventricular portion of the membranous septum, associated with a communication between the right ventricle and the right atrium through an abnormality in the tricuspid valve.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á